- ►annals.org [PDF] M Skinner, V Sanchorawala, DC Seldin, LM … - Annals of internal medicine, 2004 - Am Coll Physicians Martha Skinner, MD; Vaishali Sanchorawala, MD; David C. Seldin, MD, PhD; Laura
M. Dember, MD; Rodney H. Falk, MD; John L. Berk, MD; Jennifer J. Anderson, PhD;
Carl O'Hara, MD; Kathleen T. Finn, RN, NP; Caryn A. Libbey, MD; Janice ... Cited by 259 - Related articles - All 17 versions
- ►hematologylibrary.org G Palladini, V Perfetti, L Obici, R Caccialanza … - Blood, 2004 - bloodjournal.hematologylibrary.org From the Amyloid Center, Biotechnology Research Laboratories, Department of
Biochemistry, the Deparment of Internal Medicine and Medical Oncology, and the
Department of Applied Health Sciences, Human Nutrition Unit, University ... Cited by 131 - Related articles - All 8 versions
- ►hematologylibrary.org - Free from Publisher A Dispenzieri, RA Kyle, MQ Lacy, TM Therneau … - Blood, 2004 - bloodjournal.hematologylibrary.org Primary systemic amyloidosis (AL) is a plasma cell dyscrasia resulting in
multisystem failure and death. High-dose chemotherapy with peripheral blood stem
cell transplantation (PBSCT) has been associated with higher response rates ... Cited by 140 - Related articles - BL Direct - All 11 versions
- ►bloodjournal.org RL Comenzo, MA Gertz - Blood, 2002 - Am Soc Hematology Limited progress had been made in reversing the pathology of AL until the
mid-1990s, when patients underwent dose-intensive intravenous melphalan therapy
and autologous hematopoietic stem cell transplantation (SCT). 8-10 As the ... Cited by 212 - Related articles - BL Direct - All 11 versions
MA Gertz, MQ Lacy, A Dispenzieri, DA … - The American journal of medicine, 2002 - Elsevier Amyloid was seen clinically in the kidneys (n = 45 patients), heart (n = 32),
peripheral nerves (n = 11), and liver (n = 11). A monoclonal protein was found
in the serum in 46 patients and in the urine in 57 patients. The median ... Cited by 118 - Related articles - All 10 versions
RA Kyle, MA Gertz, PR Greipp, TE Witzig, JA … - The New England journal of medicine, 1997 - nejm.highwire.org Results The median duration of survival after randomization was 8.5 months in
the colchicine group, 18 months in the group assigned to melphalan and
prednisone, and 17 months in the group assigned to melphalan, prednisone, ... Cited by 389 - Related articles - BL Direct - All 7 versions
- ►bloodjournal.org G Palladini, V Perfetti, S Perlini, L Obici, F … - Blood, 2005 - Am Soc Hematology Based on the efficacy of thalidomide in multiple myeloma and on its synergy with
dexamethasone on myeloma plasma cells, we evaluated the combination of
thalidomide (100 mg/d, with 100-mg increments every 2 weeks, up to 400 mg) ... Cited by 72 - Related articles - All 8 versions
HJ Lachmann, R Gallimore, JD Gillmore, HD … - British Journal of Haematology, 2003 - amyloidosis.org Outcome in systemic AL amyloidosis in relation to changes ... Helen J.
Lachmann, 1 Ruth Gallimore, 1 Julian D. Gillmore, 1 Hugh D. Carr-Smith, 2 ...
Arthur R. Bradwell, 3 Mark B. Pepys 1 and Philip N. Hawkins 1 1The National ... Cited by 215 - Related articles - View as HTML - BL Direct - All 11 versions
MA Gertz, MQ Lacy, A Dispenzieri, SM Ansell, … - Bone Marrow Transplantation, 2004 - nature.com High-dose chemotherapy and autologous stem cell transplantation are used
increasingly to treat patients with light-chain-related amyloidosis (AL).
Treatment-related mortality is approximately 15%. To enable more patients ... Cited by 52 - Related articles - BL Direct - All 3 versions
- ►ascopubs.org A Dispenzieri, MQ Lacy, RA Kyle, TM … - Journal of Clinical Oncology, 2001 - jco.ascopubs.org Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
From the Division of Hematology and Internal Medicine, and Section of ... Cited by 84 - Related articles - BL Direct - All 7 versions
